Senate Finance Committee Investigates Propulsid Educational Grants
This article was originally published in The Pink Sheet Daily
A July 5 letter to J&J seeks information regarding educational grants connected to Propulsid. The committee is seeking specific dollar amounts paid to certain medical societies and names of employees who evaluated and approved educational grants.
You may also be interested in...
A letter to 23 companies from committee chair Grassley and ranking member Baucus requests disclosures about policies and financials for educational grants. The committee is exploring whether future guidance or legislation is necessary.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.